These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18624313)

  • 1. Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.
    Deng K; Adams MM; Damani P; Livingston PO; Ragupathi G; Gin DY
    Angew Chem Int Ed Engl; 2008; 47(34):6395-8. PubMed ID: 18624313
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.
    Ragupathi G; Damani P; Deng K; Adams MM; Hang J; George C; Livingston PO; Gin DY
    Vaccine; 2010 Jun; 28(26):4260-7. PubMed ID: 20450868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of potent Quillaja saponin vaccine adjuvants.
    Adams MM; Damani P; Perl NR; Won A; Hong F; Livingston PO; Ragupathi G; Gin DY
    J Am Chem Soc; 2010 Feb; 132(6):1939-45. PubMed ID: 20088518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer.
    Ragupathi G; Gardner JR; Livingston PO; Gin DY
    Expert Rev Vaccines; 2011 Apr; 10(4):463-70. PubMed ID: 21506644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.
    Ragupathi G; Livingston PO; Hood C; Gathuru J; Krown SE; Chapman PB; Wolchok JD; Williams LJ; Oldfield RC; Hwu WJ
    Clin Cancer Res; 2003 Nov; 9(14):5214-20. PubMed ID: 14614001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semisynthesis of Analogues of the Saponin Immunoadjuvant QS-21.
    Fernández-Tejada A; Walkowicz WE; Tan DS; Gin DY
    Methods Mol Biol; 2017; 1494():45-71. PubMed ID: 27718185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.
    Kim SK; Ragupathi G; Cappello S; Kagan E; Livingston PO
    Vaccine; 2000 Oct; 19(4-5):530-7. PubMed ID: 11027818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of the potent immunostimulatory adjuvant QS-21A.
    Wang P; Kim YJ; Navarro-Villalobos M; Rohde BD; Gin DY
    J Am Chem Soc; 2005 Mar; 127(10):3256-7. PubMed ID: 15755124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.
    Deng K; Adams MM; Gin DY
    J Am Chem Soc; 2008 May; 130(18):5860-1. PubMed ID: 18410100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
    Fernández-Tejada A; Tan DS; Gin DY
    Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.
    Fernández-Tejada A; Chea EK; George C; Gardner JR; Livingston PO; Ragupathi G; Tan DS; Gin DY
    Bioorg Med Chem; 2014 Nov; 22(21):5917-23. PubMed ID: 25284254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi.
    Kim YJ; Wang P; Navarro-Villalobos M; Rohde BD; Derryberry J; Gin DY
    J Am Chem Soc; 2006 Sep; 128(36):11906-15. PubMed ID: 16953631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation.
    den Brok MH; Büll C; Wassink M; de Graaf AM; Wagenaars JA; Minderman M; Thakur M; Amigorena S; Rijke EO; Schrier CC; Adema GJ
    Nat Commun; 2016 Nov; 7():13324. PubMed ID: 27819292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of QS-21-based immunoadjuvants.
    Wang P; Dai Q; Thogaripally P; Zhang P; Michalek SM
    J Org Chem; 2013 Nov; 78(22):11525-34. PubMed ID: 24147602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside vaccines with emphasis on GM2.
    Livingston P
    Semin Oncol; 1998 Dec; 25(6):636-45. PubMed ID: 9865678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
    Brunner L; Barnier-Quer C; Collin N
    Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
    Ragupathi G; Koide F; Sathyan N; Kagan E; Spassova M; Bornmann W; Gregor P; Reis CA; Clausen H; Danishefsky SJ; Livingston PO
    Cancer Immunol Immunother; 2003 Oct; 52(10):608-16. PubMed ID: 12811527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.
    Soltysik S; Wu JY; Recchia J; Wheeler DA; Newman MJ; Coughlin RT; Kensil CR
    Vaccine; 1995; 13(15):1403-10. PubMed ID: 8578817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.